Related Experiment Video
Updated: Oct 29, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
A Comparison of Hemodialysis and Peritoneal Dialysis in Patients with Cardiovascular Disease
Rehab B Albakr1, Joanne M Bargman2
1Division of Nephrology, University of Toronto, University Health Network, 200 Elizabeth Street 8N-840, Toronto, ON M5G 2C4, Canada; Division of Nephrology, College of Medicine, King Saud University, King Khalid Street, Riyadh-Al-Diriyah 12372, Saudi Arabia.
Insights
Cardiovascular disease is common in end-stage renal disease patients due to traditional and kidney disease-related factors. This review compares hemodialysis and peritoneal dialysis impacts on cardiovascular conditions in these patients.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- End-stage renal disease (ESRD) patients exhibit high cardiovascular disease (CVD) prevalence.
- Risk factors include traditional CVD risks and non-traditional factors like inflammation, anemia, and bone mineral disease.
- The dialysis procedure itself contributes to cardiovascular complications.
Purpose of the Study:
- To review and compare hemodialysis (HD) and peritoneal dialysis (PD).
- To examine the association between dialysis modalities and various cardiovascular diseases in ESRD patients.
- To highlight the importance of individualized treatment for CVD in ESRD.
Main Methods:
- Literature review comparing HD and PD.
- Analysis of cardiovascular diseases in dialysis patients.
- Focus on hypertension, coronary artery disease, myocardial stunning, arrhythmias, heart failure, and cardiorenal syndrome.
Main Results:
- Both HD and PD have distinct impacts on cardiovascular health in ESRD.
- Specific cardiovascular conditions are differentially affected by HD versus PD.
- Understanding these differences is key for tailored patient management.
Conclusions:
- Individualized treatment strategies are crucial for managing CVD in ESRD patients.
- Comparing HD and PD offers insights into optimizing cardiovascular outcomes.
- Further research into the cardiorenal syndrome in dialysis patients is warranted.
Abstract:
The high prevalence of cardiovascular disease is caused by the traditional cardiovascular risk factors common among end-stage renal disease patients, and nontraditional risk factors attributed to underlying kidney disease, including chronic inflammation, anemia, bone mineral disease, and the dialysis procedure itself. Individualization of the treatment of cardiovascular disease in end-stage renal disease that could impact the underlying mechanisms of the cardiovascular diseases is important to improve outcomes. This article reviews and compares hemodialysis and peritoneal dialysis in association with different cardiovascular diseases affecting dialysis patients, including hypertension, coronary artery disease, myocardial stunning, cardiac arrhythmias, heart failure, and the cardiorenal syndrome.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Hemodialysis I: Introduction
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Peritoneal Dialysis I: Introduction and Procedure

